Literature DB >> 30922786

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.

Omar Ahmad Hassanien1, Rasha T Abouelkheir2, Mohamed Ibrahim Abou El-Ghar3, Manal Ezzat Badawy4, Samir Abdel-Hakim El Gamal4, Mohamed Abd El-Hamid3.   

Abstract

PURPOSE: The aim of study is to assess the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and correlation with tumour angiogenesis in evaluation of urinary bladder cancer.
MATERIAL AND METHODS: The study included 81 patients with recent presumed diagnosis of bladder tumour or who came for follow up after management of histopathologically proven bladder cancer. All had DCE-MRI with time-signal intensity curve. The radiologic results then correlated with the histopathologic results using both haematoxylin and eosin stain and immuno-histochemical staining for localization and evaluation of CD34 immunoreactivity as a detector for the microvessel density (MVD) and tumour angiogenesis.
RESULTS: Seventy-one cases were pathologically proven to be malignant: 41 cases (58%) showed type III time-signal intensity curve (descending); 22 cases (31%) showed type II (plateau); and 8 cases (11%) showed type I (ascending) curve. The sensitivity of DCE-MRI in stage T1 bladder tumour was 80%; in stage T2, it was (90.9%); and in stage T3, it was (96.9%). Overall accuracy of DCE-MRI in tumour staging was 89.5% and P = .001 (significant). Values more than the cutoff value = 76.13 MVD are cystitis with sensitivity (90%), specificity (91%), and P value is .001, which is statistically highly significant.
CONCLUSION: There is a strong positive association between DCE-MRI (staging and washout slope of the time-signal intensity curve) with histopathologic grade, tumour stage, and MVD in bladder cancer. So, DCE-MRI can be used as reliable technique in preoperative predictions of tumour behavior and affect the planning of antiangiogenetic therapy.
Copyright © 2018 Canadian Association of Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamic contrast magnetic resonance imaging; Tumoral angiogenesis; Urinary bladder cancer

Mesh:

Substances:

Year:  2019        PMID: 30922786     DOI: 10.1016/j.carj.2018.11.004

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  5 in total

1.  Recent Developments in Imaging in BPS/IC.

Authors:  Teruyuki Ogawa; Pradeep Tyagi; Osamu Ishizuka; Tomohiro Ueda; Michael B Chancellor; Christopher J Chermansky; Naoki Yoshimura
Journal:  Curr Bladder Dysfunct Rep       Date:  2019-12-14

2.  Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?

Authors:  Serdar Aslan; Ismet Mirac Cakir; Ural Oguz; Tumay Bekci; Erhan Demirelli
Journal:  Abdom Radiol (NY)       Date:  2021-12-17

3.  Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.

Authors:  Shenghua Liu; Feijia Xu; Tianyuan Xu; Yang Yan; Xudong Yao; Guangyu Tang
Journal:  Transl Androl Urol       Date:  2020-04

Review 4.  Imaging of Bladder Cancer: Standard Applications and Future Trends.

Authors:  Rasha Taha Abouelkheir; Abdalla Abdelhamid; Mohamed Abou El-Ghar; Tarek El-Diasty
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

Review 5.  Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer.

Authors:  Xiaopan Xu; Huanjun Wang; Yan Guo; Xi Zhang; Baojuan Li; Peng Du; Yang Liu; Hongbing Lu
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.